These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND MSH2, COCA1, 4436, ENSG00000095002, HNPCC, FCC1, HNPCC1, P43246
3462 results:

  • 1. Prognostic implications of immunohistochemistry in patients with endometrial cancer.
    Anca-Stanciu MB; Manu A; Olinca MV; Coroleucă BC; Comandaşu DE; Coroleucă CA; Maier C; Brătilă E
    Rom J Morphol Embryol; 2024; 65(2):185-193. PubMed ID: 39020532
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Exome Sequencing Identifies Carriers of the Autosomal Dominant cancer Predisposition Disorders Beyond Current Practice Guideline Recommendations.
    Samadder NJ; Gay E; Lindpere V; Bublitz ML; Bandel LA; Armasu SM; Vierkant RA; Ferber MJ; Klee EW; Larson NB; Kruisselbrink TM; Egan JB; Kemppainen JL; Bidwell JS; Anderson JL; McAllister TM; Walker TS; Kunze KL; Golafshar MA; Klint MA; Presutti RJ; Bobo WV; Sekulic A; Summer-Bolster JM; Willman CL; Lazaridis KN
    JCO Precis Oncol; 2024 Jul; 8():e2400106. PubMed ID: 39013133
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Analysis of clinical characteristics of mismatch repair status in colorectal cancer: a multicenter retrospective study.
    Mao J; He Y; Chu J; Hu B; Yao Y; Yan Q; Han S
    Int J Colorectal Dis; 2024 Jul; 39(1):100. PubMed ID: 38967814
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Tumor-infiltrating lymphocytes, PD-L1, and MMR-deficiency combined characterization may identify subgroups of rectal cancer patients who would benefit from immunotherapy.
    Giatromanolaki A; Kavazis C; Gkegka AG; Kouroupi M; Tsaroucha A; Pitiakoudis M; Koukourakis MI
    Immunobiology; 2023 Nov; 228(6):152756. PubMed ID: 38860277
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Prevalence of Potentially Pathogenic Germline Variants Among Adult Patients in the Philippines With Solid Malignancies Who Underwent Tumor Genomic Profiling.
    Franco PI; Andal JJ; Ang DC; Que FV
    JCO Glob Oncol; 2024 Jun; 10():e2400019. PubMed ID: 38843470
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Functional analysis of MMR gene VUS from potential Lynch syndrome patients.
    Mahdouani M; Zhuri D; Sezginer Guler H; Hmida D; Sana M; Azaza M; Ben Said M; Masmoudi S; Hmila F; Youssef S; Ben Sghaier R; Brieger A; Zeuzem S; Saad A; Gurkan H; Yalcintepe S; Gribaa M; Plotz G
    PLoS One; 2024; 19(6):e0304141. PubMed ID: 38843250
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Assessing Mismatch Repair Expression by Immunohistochemistry in colorectal Adenocarcinoma -Insight from a Tertiary Care Centre.
    Lakhe R; Doshi R; Doshi P; Patil A; Nimbargi R
    Gulf J Oncolog; 2024 May; 1(45):35-41. PubMed ID: 38774931
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. The Relationship of Microsatellite Instability with BRAF and p53 Mutations and Histopathological Parameters in colorectal Adenocarcinoma.
    Gündoğar Ö; Bektaş S; Yıldırım E; Gönüllü D
    Ann Ital Chir; 2024; 95(2):181-191. PubMed ID: 38684491
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Microenvironment, systemic inflammatory response and tumor markers considering consensus molecular subtypes of colorectal cancer.
    Jakab A; Patai ÁV; Darvas M; Tormássi-Bély K; Micsik T
    Pathol Oncol Res; 2024; 30():1611574. PubMed ID: 38645565
    [No Abstract]    [Full Text] [Related]  

  • 10. Nfe2l2/NRF2 Deletion Attenuates Tumorigenesis and Increases Bacterial Diversity in a Mouse Model of Lynch Syndrome.
    Haller F; Jimenez K; Baumgartner M; Lang M; Klotz A; Jambrich M; Busslinger G; Müllauer L; Khare V; Gasche C
    Cancer Prev Res (Phila); 2024 Jul; 17(7):311-324. PubMed ID: 38643981
    [TBL] [Abstract] [Full Text] [Related]  

  • 11.
    Sun M; Moquet J; Barnard S; Mancey H; Burling D; Baldwin-Cleland R; Monahan K; Latchford A; Lloyd D; Bouffler S; Badie C; Anyamene NA; Ainsbury E
    Front Public Health; 2024; 12():1369201. PubMed ID: 38638480
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Outcomes of 10 years of PSA screening for prostate cancer in Norwegian men with Lynch syndrome.
    Grindedal EM; Zucknick M; Stormorken A; Rønne E; Tandstad NM; Isaacs WB; Axcrona K; Mæhle L
    Prostate; 2024 Jul; 84(10):945-953. PubMed ID: 38629217
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Incidence and molecular characteristics of deficient mismatch repair conditions across nine different tumors and identification of germline variants involved in Lynch-like syndrome.
    Ito T; Yamaguchi T; Kumamoto K; Suzuki O; Chika N; Kawakami S; Nagai T; Igawa T; Fujiyoshi K; Akagi Y; Arai T; Akagi K; Eguchi H; Okazaki Y; Ishida H
    Int J Clin Oncol; 2024 Jul; 29(7):953-963. PubMed ID: 38615286
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. [Expression of immune checkpoints PD-L1, CTLA4, LAG3 in the microenvironment of colon adenocarcinoma depending on MMR status].
    Naumov SS; Krakhmal NV; Tashireva LA; Vtorushin SV
    Arkh Patol; 2024; 86(2):6-13. PubMed ID: 38591901
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Mitotic abnormalities precede microsatellite instability in lynch syndrome-associated colorectal tumourigenesis.
    Pussila M; Laiho A; Törönen P; Björkbacka P; Nykänen S; Pylvänäinen K; Holm L; Mecklin JP; Renkonen-Sinisalo L; Lehtonen T; Lepistö A; Linden J; Mäki-Nevala S; Peltomäki P; Nyström M
    EBioMedicine; 2024 May; 103():105111. PubMed ID: 38583260
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Molecular characterization as new driver in prognostic signatures and therapeutic strategies for endometrial cancer.
    D'Agostino E; Mastrodomenico L; Ponzoni O; Baldessari C; Piombino C; Pipitone S; Giuseppa Vitale M; Sabbatini R; Dominici M; Toss A
    Cancer Treat Rev; 2024 May; 126():102723. PubMed ID: 38555857
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Clinical and biological landscape of constitutional mismatch-repair deficiency syndrome: an International Replication Repair Deficiency Consortium cohort study.
    Ercan AB; Aronson M; Fernandez NR; Chang Y; Levine A; Liu ZA; Negm L; Edwards M; Bianchi V; Stengs L; Chung J; Al-Battashi A; Reschke A; Lion A; Ahmad A; Lassaletta A; Reddy AT; Al-Darraji AF; Shah AC; Van Damme A; Bendel A; Rashid A; Margol AS; Kelly BL; Pencheva B; Heald B; Lemieux-Anglin B; Crooks B; Koschmann C; Gilpin C; Porter CC; Gass D; Samuel D; Ziegler DS; Blumenthal DT; Kuo DJ; Hamideh D; Basel D; Khuong-Quang DA; Stearns D; Opocher E; Carceller F; Baris Feldman H; Toledano H; Winer I; Scheers I; Fedorakova I; Su JM; Vengoechea J; Sterba J; Knipstein J; Hansford JR; Gonzales-Santos JR; Bhatia K; Bielamowicz KJ; Minhas K; Nichols KE; Cole KA; Penney L; Hjort MA; Sabel M; Gil-da-Costa MJ; Murray MJ; Miller M; Blundell ML; Massimino M; Al-Hussaini M; Al-Jadiry MF; Comito MA; Osborn M; Link MP; Zapotocky M; Ghalibafian M; Shaheen N; Mushtaq N; Waespe N; Hijiya N; Fuentes-Bolanos N; Ahmad O; Chamdine O; Roy P; Pichurin PN; Nyman P; Pearlman R; Auer RC; Sukumaran RK; Kebudi R; Dvir R; Raphael R; Elhasid R; McGee RB; Chami R; Noss R; Tanaka R; Raskin S; Sen S; Lindhorst S; Perreault S; Caspi S; Riaz S; Constantini S; Albert S; Chaleff S; Bielack S; Chiaravalli S; Cramer SL; Roy S; Cahn S; Penna S; Hamid SA; Ghafoor T; Imam U; Larouche V; Magimairajan Issai V; Foulkes WD; Lee YY; Nathan PC; Maruvka YE; Greer MC; Durno C; Shlien A; Ertl-Wagner B; Villani A; Malkin D; Hawkins C; Bouffet E; Das A; Tabori U
    Lancet Oncol; 2024 May; 25(5):668-682. PubMed ID: 38552658
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Mismatch repair protein deficiency and its implications on distant metastasis in colorectal cancer: A comprehensive analysis.
    Fan C; Fang C; Wang W; Lv Z; Zhang X; Long F; Jiang Z; Li Y; Zhang H; Zhou ZG; Wang C; Sun XF
    Cancer Med; 2024 Apr; 13(7):e6994. PubMed ID: 38545852
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Epigenetic MLH1 silencing concurs with mismatch repair deficiency in sporadic, naturally occurring colorectal cancer in rhesus macaques.
    Deycmar S; Johnson BJ; Ray K; Schaaf GW; Ryan DP; Cullin C; Dozier BL; Ferguson B; Bimber BN; Olson JD; Caudell DL; Whitlow CT; Solingapuram Sai KK; Romero EC; Villinger FJ; Burgos AG; Ainsworth HC; Miller LD; Hawkins GA; Chou JW; Gomes B; Hettich M; Ceppi M; Charo J; Cline JM
    J Transl Med; 2024 Mar; 22(1):292. PubMed ID: 38504345
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Cascade screening in HBOC and Lynch syndrome: guidelines and procedures in a UK centre.
    Evans DG; Green K; Burghel GJ; Forde C; Lalloo F; Schlecht H; Woodward ER
    Fam Cancer; 2024 Jun; 23(2):187-195. PubMed ID: 38478259
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 174.